Title : Body weight and eGFR during dulaglutide treatment in type 2 diabetes and moderate-to-severe chronic kidney disease (AWARD-7).

Pub. Date : 2019 Jun

PMID : 30762290






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 BW decreased with dulaglutide 1.5 and 0.75 mg and increased with insulin glargine ([LSM change (SE)], -2.66 [0.47] kg and -1.71 [0.45] vs 1.57 [0.43] kg; P < 0.001). Insulin Glargine insulin Homo sapiens